Clinical Outcomes of Concomitant Use of Proton Pump Inhibitors and Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis

Background: The safety and efficacy associated with the use of proton pump inhibitors (PPIs) by patients with coronary artery disease receiving dual antiplatelet therapy (DAPT) remain unclear. Methods: The evaluated outcomes included combined major adverse cardiovascular events (MACEs), myocardial i...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hongzhou, Ye, Zhishuai, Huang, Rongchong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366318/
https://www.ncbi.nlm.nih.gov/pubmed/34408652
http://dx.doi.org/10.3389/fphar.2021.694698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366318/
https://www.ncbi.nlm.nih.gov/pubmed/34408652
http://dx.doi.org/10.3389/fphar.2021.694698

Ejemplares similares